The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.
News Medical on MSN10d
Non-Opioid Pain Medication Found To Be Effective in Animal ModelsA research team has developed a non-opioid medication that shows promise in treating acute and chronic pain. The drug, known ...
During my time serving in the state legislature, I heard from numerous constituents impacted by the opioid crisis ...
New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.
Chronic pain, which lasts for three months or longer, is difficult to treat. Many people rely on opioid pain medications, but ...
Investing.com -- Vertex Pharmaceuticals Inc (NASDAQ: VRTX ).’s newly approved non-opioid pain medication, Journavx, has been included in UnitedHealth Group Inc (NYSE: UNH ).’s coverage, according to ...
Medical Xpress on MSN10d
Compound mimics cannabis for pain relief without the side effects: Mouse study points to effective opioid alternativeDespite widespread public health warnings and media attention focused on the dangers of opioid addiction ... of nerve-injury ...
Vertex Pharmaceuticals Inc.’s new non-opioid painkiller ... might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists. The medication, called Journavx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback